Komaroff Eugene

🇴🇲 Keiser University

2 articles in GJC

Treatment and vision-related quality of life in the early manifest glaucoma trial.

Hyman Leslie G, Komaroff Eugene, Heijl Anders, Bengtsson Bo, Leske M Cristina

OphthalmologySep 2005133 citationsRandomized Controlled Trial

This study found early glaucoma treatment didn't impact vision-related quality of life, but visual function (acuity, field) significantly affected it for up to six years.

Full abstract PubMed

Factors for progression and glaucoma treatment: the Early Manifest Glaucoma Trial.

Leske M Cristina, Heijl Anders, Hyman Leslie, Bengtsson Bo, Komaroff Eugene

Curr Opin OphthalmolApr 2004168 citationsReview

The EMGT found early glaucoma treatment (IOP lowering) halved progression risk, highlighting its value, while age and disease severity also predicted worsening.**

Full abstract PubMed

All 2 articles loaded

Global Search

Komaroff Eugene

Treatment and vision-related quality of life in the early manifest glaucoma trial.

Factors for progression and glaucoma treatment: the Early Manifest Glaucoma Trial.